KFBL

Kothari Fermanatation & Biochem financials

Market cap
₹61 Cr

Quarterly results

Q1 FY27: revenue up 28.0%, net profit up 105.4% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue25 31 32 24 24 −5%32 +5%32 +1%30 +28%
EBITDA1 3 4 2 -0 −151%2 −25%3 −34%3 +59%
Net profit-2 0 1 -1 -3 −76%-0 −193%1 +21%0 +105%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance −17.9% 1Y

₹35.0₹40.0₹45.0₹50.0Sept 25Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26

1Y: ₹49 on 9 Sept 2025 → ₹40.24. High ₹50.75 (23 Oct 2025), low ₹34.01 (30 Mar 2026).

Financials, as filed

Revenue grew 1.5% a year over 2 years, FY24 to FY26. Operating margin widened to 5.8%.

Year endingFY24FY25FY26
Revenue₹109 Cr₹114 Cr₹112 Cr
Operating profit₹5 Cr₹12 Cr₹7 Cr
Operating margin4.7%10.4%5.8%
Interest₹3 Cr₹4 Cr₹4 Cr
Depreciation₹6 Cr₹6 Cr₹7 Cr
Net profit₹-5 Cr₹1 Cr₹-3 Cr
Net margin-4.5%0.7%-3.0%
Cash from operations₹9 Cr₹11 Cr₹5 Cr
Free cash flow₹1 Cr₹7 Cr₹-1 Cr
ROCE0.0%5.0%0.0%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹15 Cr₹15 Cr₹15 Cr₹15 Cr₹15 Cr₹15 Cr
Reserves₹45 Cr₹46 Cr₹46 Cr₹41 Cr₹37 Cr₹39 Cr
Borrowings₹39 Cr₹45 Cr₹45 Cr₹47 Cr₹42 Cr₹48 Cr
Other liabilities₹17 Cr₹23 Cr₹26 Cr₹29 Cr₹29 Cr₹25 Cr
Total liabilities₹116 Cr₹129 Cr₹131 Cr₹132 Cr₹124 Cr₹127 Cr
Fixed assets₹82 Cr₹80 Cr₹74 Cr₹87 Cr₹89 Cr₹85 Cr
Capital work in progress₹7 Cr₹16 Cr₹19 Cr₹8 Cr₹1 Cr₹6 Cr
Investments₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Other assets₹28 Cr₹33 Cr₹38 Cr₹37 Cr₹34 Cr₹36 Cr
Total assets₹116 Cr₹129 Cr₹131 Cr₹132 Cr₹124 Cr₹127 Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

Since Jun 2025, promoters trimmed −1.28 pp while the public added +1.26 pp. The shareholder count shrank 2% to 11,421.

Promoters
68.9%
Public
31.1%

Since Jun 2025

  • Promoters −1.28 pp
  • Public +1.26 pp

How it drifted, 12 quarters

Over this window promoters fell from 74.9% to 68.9% — −6.0 pp.

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 74.9%, Public 25.1%.Dec '23: Promoters 74.9%, Public 25.1%.Mar '24: Promoters 74.9%, Public 25.1%.Jun '24: Promoters 74.9%, Public 25.1%.Sep '24: Promoters 74.9%, Public 25.1%.Dec '24: Promoters 72.4%, Public 27.6%.Mar '25: Promoters 71.7%, Public 28.3%.Jun '25: Promoters 70.2%, Public 29.9%.Sep '25: Promoters 68.9%, Public 31.1%.Dec '25: Promoters 68.9%, Public 31.1%.Mar '26: Promoters 68.9%, Public 31.1%.Jun '26: Promoters 68.9%, Public 31.1%.

Who was buying across the market this quarter →

Who is on the register

Named in the Jun 2026 filing

Every holder of Kothari Fermanatation & Biochem Ltd above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
Siddhant Kothari 24.85%unchanged
Pramod Kumar Kothari(Huf) 16.34%unchanged
Chaudhry Brothers Traders And Builders Private Limited 13.59%unchanged
Kavita Devi Kothari 4.87%unchanged
Pramod Kumar Kothari 4.76%unchanged
Sampat Devi Kothari 2.44%unchanged
Moti Lal Kothari(Huf) 2.01%unchanged
Dheeraj Kumar Lohia 1.36%unchanged
Ashish Chugh 1.18%unchanged
Mahendra Girdharilal 1.05%unchanged
Satya Prakash Mittal 1.01%unchanged

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

Learn to analyse Kothari Fermanatation & Biochem Ltd

Guides on how to read this kind of business and the numbers that matter.